GENEVA, Sept. 18 -- HANGZHOU JIUYUAN GENETIC BIOPHARMACEUTICAL CO., LTD. filed a patent application (CN2026/080761) for “LONG-ACTING HUMAN AMYLIN ANALOGUE AND USE THEREOF”. With publication no. WO/2026/184507, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/575
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....